About us
coIMMUNE is a privately held, clinical stage immune-oncology company that will redefine cancer treatment using best-in-class cellular immunotherapies. Our allogeneic CAR-CIK technology platform for liquid and solid tumors is a novel CAR therapy that promises enhanced efficacy with greatly reduced toxicity.
- Industry
- Research
- Company size
- 11-50 employees
- Headquarters
- Durham, North Carolina
- Type
- Privately Held
Locations
-
Primary
Get directions
4233 Technology Dr
Durham, North Carolina 27704, US